Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries.

BACKGROUND Few studies have evaluated the independent effect of a cancer diagnosis on vulnerability and frailty, which have been associated with adverse health outcomes in older adults. METHODS We used data in the 2003 Medicare Current Beneficiary Survey from a nationally representative sample of 12,480 community-dwelling elders. Multivariable logistic regression models were used to evaluate whether cancer was independently associated with vulnerability and frailty. Measures of vulnerability and frailty included disability, geriatric syndromes, self-rated health, and scores on two assessment tools for elderly cancer patients-the Vulnerable Elders Survey-13 (VES-13) and the Balducci frailty criteria. All statistical tests were two-sided. RESULTS Diagnosis of a non-skin cancer was reported by 18.8% of the respondents. Compared with respondents without a cancer history, respondents with a personal history of cancer had a statistically significantly higher prevalence of limitations in activities of daily living (31.9% vs 26.9%), limitations in instrumental activities of daily living (49.5% vs 42.3%), geriatric syndromes (60.8% vs 53.9%), low self-rated health (27.4% vs 20.9%), score of 3 or higher on the VES-13 (45.8% vs 39.5%), and satisfying criteria for frailty as defined by Balducci (79.6% vs 73.4%) (P < .001 for all characteristics). After adjustment for confounders, a cancer diagnosis was found to be associated with low self-rated health (adjusted odds ratio [OR] = 1.46, 95% confidence interval [CI] = 1.30 to 1.64; relative risk [RR] = 1.33), limitations in activities of daily living (adjusted OR = 1.19, 95% CI = 1.06 to 1.33; RR = 1.13), limitations in instrumental activities of daily living (adjusted OR = 1.25, 95% CI = 1.13 to 1.38; RR = 1.13), a geriatric syndrome (adjusted OR = 1.27, 95% CI = 1.15 to 1.41; RR = 1.11), VES-13 score of 3 or higher (adjusted OR = 1.26, 95% CI = 1.13 to 1.41; RR = 1.14), and frailty (adjusted OR = 1.46, 95% CI = 1.29 to 1.65; RR = 1.09) as defined by Balducci criteria. CONCLUSION Diagnosis of a non-skin cancer was associated with increased levels of having disability, having geriatric syndromes, and meeting criteria for vulnerability and frailty.

[1]  H. Cohen,et al.  Senior adult oncology clinical practice guidelines in oncology. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  S. Monfardini,et al.  Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program. , 2008, Critical reviews in oncology/hematology.

[3]  S. Mohile,et al.  Does androgen‐deprivation therapy accelerate the development of frailty in older men with prostate cancer? , 2007, Cancer.

[4]  S. Gibson,et al.  Geriatric syndromes as predictors of adverse outcomes of hospitalization , 2007, Internal medicine journal.

[5]  S. Mohile,et al.  A practical approach to geriatric assessment in oncology. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Stephanie Studenski,et al.  Geriatric Syndromes: Clinical, Research, and Policy Implications of a Core Geriatric Concept , 2007, Journal of the American Geriatrics Society.

[7]  L. Pientka,et al.  How many and which items of activities of daily living (ADL) and instrumental activities of daily living (IADL) are necessary for screening. , 2007, Critical reviews in oncology/hematology.

[8]  Cynthia M Boyd,et al.  Framework for evaluating disease severity measures in older adults with comorbidity. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  J. Dignam,et al.  A pilot study of the vulnerable elders survey‐13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation , 2007, Cancer.

[10]  D. Carr,et al.  Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  E. Madigan,et al.  Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Elliott,et al.  Higher Vulnerable Elders Survey Scores Predict Death and Functional Decline in Vulnerable Older People , 2006, Journal of the American Geriatrics Society.

[13]  H. Cohen,et al.  Developing a cancer‐specific geriatric assessment , 2005, Cancer.

[14]  C. Forrest,et al.  Disparities Despite Coverage , 2005 .

[15]  H. Cohen,et al.  Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). , 2005, Critical reviews in oncology/hematology.

[16]  D. Meltzer,et al.  Use of a Self-Report-Generated Charlson Comorbidity Index for Predicting Mortality , 2005, Medical care.

[17]  V. Allgar,et al.  Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the ‘National Survey of NHS Patients: Cancer’ , 2005, British Journal of Cancer.

[18]  Chad Boult,et al.  Newly Reported Chronic Conditions and Onset of Functional Dependency , 2005, Journal of the American Geriatrics Society.

[19]  M. Piccart,et al.  Adjuvant therapy in elderly patients with breast cancer. , 2004, Clinical breast cancer.

[20]  E. Skovlund,et al.  A simple approach to power and sample size calculations in logistic regression and Cox regression models , 2004, Statistics in medicine.

[21]  L. Ferrucci,et al.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[22]  L. Balducci.  Management of cancer pain in geriatric patients. , 2003, The journal of supportive oncology.

[23]  S. Bandinelli,et al.  The frailty syndrome: a critical issue in geriatric oncology. , 2003, Critical reviews in oncology/hematology.

[24]  A. Laupacis,et al.  Drug-drug interactions among elderly patients hospitalized for drug toxicity. , 2003, JAMA.

[25]  S. Sternberg.  THE VULNERABLE ELDERS SURVEY: A TOOL FOR IDENTIFYING VULNERABLE OLDER PEOPLE IN THE COMMUNITY , 2003, Journal of the American Geriatrics Society.

[26]  L. Balducci,et al.  A case for geriatric oncology. , 2002, The Lancet. Oncology.

[27]  A. Naeim,et al.  Geriatric syndromes and assessment in older cancer patients. , 2001, Oncology.

[28]  J Z Ayanian,et al.  Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. , 2001, JAMA.

[29]  H. Hendrie,et al.  Cognitive Impairment and Mortality in Older Primary Care Patients , 2001, Journal of the American Geriatrics Society.

[30]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[31]  L. Balducci.  The geriatric cancer patient: equal benefit from equal treatment. , 2001, Cancer control : journal of the Moffitt Cancer Center.

[32]  L. Repetto,et al.  Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients. , 2001, Critical reviews in oncology/hematology.

[33]  R. Hays,et al.  Identifying a short functional disability screen for older persons. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[34]  M. Extermann,et al.  Management of cancer in the older person: a practical approach. , 2000, The oncologist.

[35]  C D Naylor,et al.  Dealing with missing data in observational health care outcome analyses. , 2000, Journal of clinical epidemiology.

[36]  H. Cohen,et al.  Clinical research in the older cancer patient. , 2000, Hematology/oncology clinics of North America.

[37]  M. Extermann,et al.  Management of the frail person with advanced cancer. , 2000, Critical reviews in oncology/hematology.

[38]  M. Extermann,et al.  Cancer and aging. An evolving panorama. , 2000, Hematology/oncology clinics of North America.

[39]  J. Zhang,et al.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.

[40]  J Concato,et al.  Importance of functional measures in predicting mortality among older hospitalized patients. , 1998, JAMA.

[41]  G. Lyman,et al.  Comorbidity and functional status are independent in older cancer patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  P. Cyr,et al.  The impact of cancer on the physical function of the elderly and their utilization of health care , 1997, Cancer.

[43]  D B Reuben,et al.  Value of functional status as a predictor of mortality: results of a prospective study. , 1992, The American journal of medicine.

[44]  A. Stewart,et al.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. , 1989, JAMA.

[45]  A. Macieira-Coelho,et al.  Cancer and aging , 1986, Experimental Gerontology.

[46]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[47]  Lodovico Balducci,et al.  Aging, frailty, and chemotherapy. , 2007, Cancer control : journal of the Moffitt Cancer Center.

[48]  L. Balducci.  Epidemiology of cancer and aging. , 2005, The Journal of oncology management : the official journal of the American College of Oncology Administrators.

[49]  Ack,et al.  LOWER-EXTREMITY FUNCTION IN PERSONS OVER THE AGE OF 70 YEARS AS A PREDICTOR OF SUBSEQUENT DISABILITY , 2001 .

[50]  William H. Rogers,et al.  Functional Status and Well-Being of Patients with Chronic Conditions , 1989 .

[51]  M P Lawton,et al.  Scales to measure competence in everyday activities. , 1988, Psychopharmacology bulletin.

[52]  S. Katz.  Studies of illness in the aged , 1963 .